CRBP2 Fundamental Analysis - CRCAM BRIE PIC2-CCI

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to CRBP2. CRBP2 was compared to 89 industry peers in the Banks industry. CRBP2 may be in some trouble as it scores bad on both profitability and health. CRBP2 does not seem to be growing, but still is valued expensively. CRBP2 also has an excellent dividend rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

CRBP2 had positive earnings in the past year.

CRBP2 had a negative operating cash flow in the past year.

In the past 5 years CRBP2 has always been profitable.

The reported operating cash flow has been mixed in the past 5 years: CRBP2 reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of 0.49%, CRBP2 is not doing good in the industry: 64.04% of the companies in the same industry are doing better.

The Return On Equity of CRBP2 (3.71%) is worse than 74.16% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.49%
ROE	3.71%
ROIC	N/A

ROA(3y)0.47%

ROA(5y)0.46%

ROE(3y)3.92%

ROE(5y)3.92%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

CRBP2 has a Profit Margin (23.60%) which is comparable to the rest of the industry.

CRBP2's Profit Margin has declined in the last couple of years.

The Operating Margin and Gross Margin are not available for CRBP2 so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	23.6%
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-6.32%

PM growth 5Y-2.49%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

CRBP2 does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for CRBP2 has been reduced compared to 1 year ago.

Compared to 5 years ago, CRBP2 has more shares outstanding

CRBP2 has a better debt/assets ratio than last year.

2.2 Solvency

CRBP2 has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.14, CRBP2 belongs to the top of the industry, outperforming 86.52% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACC5.8%

2.3 Liquidity

		Industry Rank	Sector Rank
Current Ratio	N/A
Quick Ratio	N/A

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.85% over the past year.

The Earnings Per Share has been growing slightly by 1.97% on average over the past years.

The Revenue has been growing slightly by 0.54% in the past year.

CRBP2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.72% yearly.

EPS 1Y (TTM)0.85%

EPS 3Y-3.01%

EPS 5Y1.97%

EPS Q2Q%-8.45%

Revenue 1Y (TTM)0.54%

Revenue growth 3Y3.81%

Revenue growth 5Y4.72%

Sales Q2Q%-1.51%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.45, the valuation of CRBP2 can be described as very cheap.

Compared to the rest of the industry, the Price/Earnings ratio of CRBP2 indicates a rather cheap valuation: CRBP2 is cheaper than 85.39% of the companies listed in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 27.03, CRBP2 is valued rather cheaply.

		Industry Rank	Sector Rank
PE	7.45
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)3.78

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CRBP2 has a Yearly Dividend Yield of 4.16%, which is a nice return.

CRBP2's Dividend Yield is slightly below the industry average, which is at 5.09.

CRBP2's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.

		Industry Rank	Sector Rank
Dividend Yield	4.16%

5.2 History

The dividend of CRBP2 has a limited annual growth rate of 1.20%.

Dividend Growth(5Y)1.2%

Div Incr Years3

Div Non Decr Years3

5.3 Sustainability

19.53% of the earnings are spent on dividend by CRBP2. This is a low number and sustainable payout ratio.

The dividend of CRBP2 is growing, but earnings are growing more, so the dividend growth is sustainable.

DP19.53%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CRCAM BRIE PIC2-CCI

EPA:CRBP2 (9/10/2025, 7:00:00 PM)

27.135

+0.01 (+0.04%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupBanks

GICS IndustryBanks

Earnings (Last)07-25 2025-07-25

Earnings (Next)10-28 2025-10-28

Inst Owners4.17%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap434.43M

Analysts83.64

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.16%

Yearly Dividend0.71

Dividend Growth(5Y)1.2%

DP19.53%

Div Incr Years3

Div Non Decr Years3

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	7.45
Fwd PE	N/A
P/S	0.51
P/FCF	N/A
P/OCF	N/A
P/B	0.08
P/tB	0.08
EV/EBITDA	N/A

EPS(TTM)3.64

EY13.41%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-122.25

FCFYN/A

OCF(TTM)-121.47

OCFYN/A

SpS52.71

BVpS335.37

TBVpS335.36

PEG (NY)N/A

PEG (5Y)3.78

Profitability

		Industry Rank	Sector Rank
ROA	0.49%
ROE	3.71%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	23.6%
GM	N/A
FCFM	N/A

ROA(3y)0.47%

ROA(5y)0.46%

ROE(3y)3.92%

ROE(5y)3.92%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3Y-6.32%

PM growth 5Y-2.49%

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.02

Health

		Industry Rank	Sector Rank
Debt/Equity	0.14
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	61.45%
Cap/Sales	1.46%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	N/A
Quick Ratio	N/A
Altman-Z	N/A

F-Score4

WACC5.8%

ROIC/WACCN/A

Cap/Depr(3y)66.63%

Cap/Depr(5y)90.89%

Cap/Sales(3y)1.62%

Cap/Sales(5y)2.37%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)0.85%

EPS 3Y-3.01%

EPS 5Y1.97%

EPS Q2Q%-8.45%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)0.54%

Revenue growth 3Y3.81%

Revenue growth 5Y4.72%

Sales Q2Q%-1.51%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1YN/A

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-57.44%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-58.45%

OCF growth 3YN/A

OCF growth 5YN/A

CRCAM BRIE PIC2-CCI (CRBP2.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens